抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
Tyrosine kinase inhibitor，99% | C31H31FN6O5 | |||
|
|
|||||
|
Glesatinib (hydrochloride)，98% | C31H27ClF2N5O3S2X | |||
|
|
|||||
|
ALW-II-41-27，99% | C32H32F3N5O2S | |||
|
|
|||||
|
DCC-2618，99% | C26H21F2N5O3 | |||
|
|
|||||
|
Savolitinib，99% | C17H15N9 | |||
|
|
|||||
|
c-Met inhibitor 1，98% | C17H14N8S | |||
|
|
|||||
|
Dihexa，98% | C27H44N4O5 | |||
|
|
|||||
|
Tavilermide，98% | C24H32N6O11 | |||
|
|
|||||
|
LM22A-4,神經(jīng)營養(yǎng)性BDNF模擬物，≥98% | C15H21N3O6 | |||
|
|
|||||
|
AIM-100，99% | C23H21N3O2 | |||
|
|
|||||
|
PLX647，98% | C21H17F3N4 | |||
|
|
|||||
|
|
c-Fms-IN-3，99% | C23H30N6O | |||
|
|
|||||
|
ISCK03，98% | C19H21N3O2S | |||
|
|
|||||
|
PF-04217903 (methanesulfonate)，98% | C20H20N8O4S | |||
|
|
|||||
|
ANA-12，98% | C22H21N3O3S | |||
|
|
|||||
|
RU-301，98% | C??H??F?N?O?S | |||
|
|
|||||
